IRCT20210718051922N1
Recruiting
Phase 2
Evaluation of effect of Hemoperfusion in patients with COVID-19 in Hajar hospital, shahrekord
Shahre-kord University of Medical Sciences0 sites60 target enrollmentTBD
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Shahre-kord University of Medical Sciences
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with severe progressive pulmonary involvement
- •Have a positive PCR test
- •Patients who are currently under mechanical ventilation or will need it in the near future.
Exclusion Criteria
- •Patients with shock symptoms
- •Patients with multiple organ failure
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Hemoperfusion effect in treatment of patients with COVID-19IRCT20110425006280N12Vice President of Research Guilan university of medical sciences20
Recruiting
Not Applicable
Efficacy of the Hemoperfusion Therapy in Patients with Severe COVID-19-Associated Pneumonia: An Experience from Single-center Observational StudySevere COVID-19-associated pneumonia with or without hemoperfusion therapyHemoperfusion, adsorption therapy, COVID-19, Pneumonia, Acute respiratory distress syndrome, Critical care, SARS-CoV2, cytokine storm, blood purificationTCTR20210627002Faculty of Medicine, Chiang Mai University15
Recruiting
Phase 2
The role of hemoperfusion in COVID-19COVID-19.COVID-19U07.1IRCT20200608047686N2Shahid Beheshti University of Medical Sciences40
Completed
Phase 2
Hemoperfusion in patients with COVID-19IRCT20150704023055N2Babol University of Medical Sciences10
Completed
Not Applicable
Investigation of the effect of direct hemoperfusion with polymyxin B-immobilized fiber on steroid resistant drug-induced lung injury.JPRN-UMIN000017263Graduate School of Medicine, Osaka City University20